Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 1.200
-0.200 (-14.29%)
Feb 23, 2026, 8:09 AM CET
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of €1.23 million as of February 23, 2026. Its market cap has increased by 75.36% in one year.
Market Cap
1.23M
Enterprise Value
11.85M
Revenue
4.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.20
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 52.02M to 1.23M, a decrease of -97.64%. That is a compound annual growth rate of -27.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.23M | 55.56% |
| Dec 30, 2025 | 789.25K | -19.48% |
| Dec 30, 2024 | 980.17K | -38.24% |
| Dec 29, 2023 | 1.59M | -76.50% |
| Dec 30, 2022 | 6.75M | -17.48% |
| Dec 30, 2021 | 8.18M | -57.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.72B |
| Siemens Healthineers AG | 47.25B |
| Bayer Aktiengesellschaft | 42.91B |
| Fresenius SE & Co. KGaA | 29.32B |
| Maternus-Kliniken Aktiengesellschaft | 20.34M |
| aap Implantate AG | 20.17M |
| NanoRepro AG | 18.48M |
| Biofrontera AG | 16.35M |